4.7 Review

SIRT2 as a therapeutic target for age-related disorders

期刊

FRONTIERS IN PHARMACOLOGY
卷 3, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2012.00082

关键词

SIRT2; aging; metabolic syndrome; cancer; neurodegenerative disorder

资金

  1. Michael J. Fox Foundation
  2. European Commission
  3. FCT [SFRH/BPD/41416/2007]
  4. NIH [1U01NS066912-01A]
  5. Fundação para a Ciência e a Tecnologia [SFRH/BPD/41416/2007] Funding Source: FCT

向作者/读者索取更多资源

Sirtuin proteins are conserved regulators of aging that have recently emerged as important modifiers of several diseases which commonly occur later in life such as cancer, diabetes, cardiovascular, and neurodegenerative diseases. In mammals, there are seven sirtuins (SIRT1-7), which display diversity in subcellular localization and function. SIRT1 has received much of attention due to its possible impact on longevity, while important biological and therapeutic roles of other sirtuins have been underestimated and just recently recognized. Here we focus on SIRT2, a member of the sirtuin family, and discuss its role in cellular and tissue-specific functions. This review summarizes the main scientific advances on SIRT2 protein biology and explores its potential as a therapeutic target for treatment of age-related disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据